A new Whitepaper from Taconic Biosciences is now available to download entitled ‘An Introduction to Humanized Immune System Mouse Models‘. Traditional mouse models have limitations in recapitulating human biology — but humanised immune system (HIS) mice offer a more predictive approach. These advanced models bring you closer to clinical… Read More
Unlock the power of humanised immune system mice. Traditional mouse models have limitations in recapitulating human biology — but humanised immune system (HIS) mice offer a more predictive approach. These advanced models bring you closer to clinical relevance. Download this Whitepaper to discover: The evolution of immunodeficient mice Key humanisation… Read More
Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics. A new whitepaper from Taconic Biosciences delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions. You will learn about: The significance of… Read More
Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics. Our whitepaper delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions. You will learn about: The significance of HIS models in bridging the… Read More
This paid-for advertorial by Taconic Biosciences appeared in DDW Volume 25 – Issue 3, Summer 2024. Harnessing the power of sophisticated GEMs and humanized mice is essential to moving research forward. In the dynamic landscape of drug discovery, the utilisation of high-quality animal models is paramount for success. Among these… Read More
This is the latest episode of the free DDW narrated podcast, “Immunotherapy, avelumab and protecting the immunocompromised”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Mice with humanised immune systems advance cell-based immunotherapy”, “… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. Read More
Listen to this article on the DDW Podcast: By Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences. Although immunotherapy has revolutionised cancer therapy, the effectiveness of currently available immunotherapies varies significantly across patients and treatment types. As a result, researchers are striving to continually improve immuno-oncology approaches using the… Read More
